ICU CONNECT: Study Comparing EMG in Healthy Volunteers and ICU Patients.
Endeavor Health · NCT07699562
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 24
- US sites recruiting
- 1
- Study start
- June 2026
- Record last updated
- July 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is testing whether a non-invasive nerve monitoring device (TetraGraph) can accurately detect early signs of ICU-acquired weakness by comparing readings from the device with standard nerve conduction/EMG tests done by a specialist to see if they match. They will focus on muscle response signals in the hand and leg over about 10 days in three groups: healthy volunteers, ICU patients who are not on ventilators, and ICU patients who are on ventilators.
Being studied: TetraGraph; Electromyography; Nerve conduction studies
Conditions: ICU Acquired Weakness
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Cohort 1: Healthy volunteers
Inclusion criteria
- Subjects must be > 18 years old and \< 90 years old.
- Subjects must consent to participate. Cohort 2: Non-intubated critically ill patients
Inclusion criteria
- Subjects may be male or female.
- Subjects must be > 18 years old and \< 90 years old.
- Subjects must have a POA or next of kin who is able to consent (for those in the ICU and who are unable to consent themselves).
Cohort 3: Intubated critically ill patients
Inclusion criteria
- Subjects may be male or female.
- Subjects must be > 18 years old and \< 90 years old.
- Subjects must have a POA or next of kin who is able to consent (for those in the ICU and who are unable to consent themselves).
- For the Subjects in the ICU that are intubated, they must be planned to be intubated for at least 24 hours.
- Subjects must be intubated for no longer than ≥ 72 hours before enrollment.
Exclusion Criteria
- Cohort 1: Healthy volunteers
Exclusion criteria
- Subjects with previous paralysis or neuromuscular disease.
- Subjects with spinal cord or brain injuries that impact motor function.
- Subjects with an allergy to clinical adhesive or hydrogel. Cohort 2: Non-intubated critically ill patients
Exclusion criteria
- Subjects with previous paralysis or neuromuscular diseases.
- Subjects with previous peripheral nerve injuries to the tested limbs.
- Subjects with spinal cord or brain injuries (including stroke) that impact motor function.
- Subjects without a POA or next of kin for those patients that are unable to consent themselves.
- Subjects with an allergy to clinical adhesive or hydrogel. Cohort 3: Intubated critically ill patients
Exclusion criteria
- Subjects with previous paralysis or neuromuscular disease
- Subjects with previous peripheral nerve injuries to the tested limbs.
- Subjects with spinal cord or brain injuries that impact motor function.
- Subjects without a POA or next of kin for those patients that are in the intubated arm.
- Subjects with intubations expected to last less than 24 hours.
- Subjects who have already been intubated for > 72 hours.
- Subjects with an allergy to clinical adhesive or hydrogel.
Recruiting US locations
Endeavor Health
Evanston, IL 60201
Site contact: Jessica Brickner · 847-570-1197 · jessica.brickner@endeavorhealth.org
Study contacts (from the official record)
- Jessica Brickner · 847-570-1197 · jessica.brickner@endeavorhealth.org
- Nia Moragne · 847-570-1197 · nia.moragne@endeavorhealth.org
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65